Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Chrysosplenol D
Cat. No.:
0225LY-1070
Appearance:
Solid
Purity:
≥97%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Chrysosplenol D functions as an efflux pump inhibitor, which can be used to enhance the efficacy of antimalarial drugs and commercial antibiotics.
Synonym:
14965-20-9; Quercetagetin 3,6,7-Trimethyl ether; Chrysoplenol D; 3,6,7-trimethylquercetagetin; 5,3',4'-Trihydroxy-3,6,7-trimethoxyflavone; 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,6,7-trimethoxychromen-4-one; 3',4',5-Trihydroxy-3,6,7-trimethoxyflavone; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,6,7-trimethoxy-; 2-(3,4-Dihydroxyphenyl)-5-hydroxy-3,6,7-trimethoxy-4H-1-benzopyran-4-one; Flavone, 3',4',5-trihydroxy-3,6,7-trimethoxy-
CAS No.:
14965-20-9
Compound CID:
5280699
Formula:
C18H16O8
Formula Weight:
360.31
Specification
Targets&IC50:
Viability: 11.6 µM(MDA-MB-231 TNBC cells)
Relative Density:
1.54 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Chrysosplenol D can be used in virology research to examine its inhibitory activity against specific viral proteases.
Library Information
Target:
JNK; NF-κB; IL receptor
Receptor:
JNK; NF-κB; IL receptor
Pathways:
Immunology/Inflammation; MAPK; NF-κB
Plate Number:
AOCL-14
Plate Location:
g5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
55 mg/mL; 152.65 mM
